HIV

May 05, 2022

In people with HIV, killer T cells (CD8+ T cells) lack a protein called CD73, which is necessary for migration and cell movement into the tissue.

May 04, 2022

Letter from co-chairs Marlene McNeese and John Wiesman urges enforcement of coverage rules, including zero cost sharing for those with private insurance.

May 03, 2022

The oral run-in period for the injectable is now optional. The FDA also approved a label change that opens the door for adolescents to be treated with long-acting HIV treatment.

April 05, 2022

HIV PrEP uptake was highest for White and Black males and lowest for Hispanic males. Meanwhile, Black females had the highest uptake and twice the rate of PrEP uptake of White females.

April 04, 2022

The proposed funds include $165 million more for the Ryan White HIV/AIDS Program, $47 million more for HIV and hepatitis prevention activities at the Indian Health Service, and $115 million for CDC HIV prevention programs.

April 03, 2022

Long-acting injectable holds advantages over daily pills for pre-exposure prophylaxis against HIV, says ViiV executive.

March 07, 2022

The decades-long quest for a vaccine against HIV has been fruitless so far. Moderna hopes an HIV vaccine that uses its messenger RNA technology will break the losing streak. A phase 1 trial designed to include 56 volunteers has started.

March 07, 2022

March 07, 2022

Physicians who are reluctant or even opposed to broad use of pre-exposure prophylaxis (PrEP) against HIV may keep physician assistants and nurse practitioners from prescribing the antivirals that can prevent infection and spread of HIV. Making PrEP an over-the-counter treatment would be one way of increasing access.

February 11, 2022